Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Aug 13, 2008 at 5:49 AM EDT

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen…

Douglas A. McIntyre | Aug 7, 2008 at 7:17 AM EDT

Illumina Gets Secondary Behind It (ILMN)

Illumina Inc. (NASDAQ: ILMN) has priced its proposed secondary offering of 3.5 million shares at $87.50 per share. This will…

Douglas A. McIntyre | Aug 4, 2008 at 4:15 PM EDT

Alnylam Cancels Conference… What’s Brewing? (ALNY)

We just saw a report out of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) that may get traders moving on both sides…

Douglas A. McIntyre | Aug 4, 2008 at 8:21 AM EDT

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY)…

Douglas A. McIntyre | Aug 1, 2008 at 10:16 AM EDT

CardioNet Defies Prior Secondary Trends (BEAT)

CardioNet, Inc. (NASDAQ: BEAT) is holding up rather well considering the discount pricing of a secondary offering. The company sold…

Douglas A. McIntyre | Aug 1, 2008 at 9:24 AM EDT

Why Biogen & Elan TYSABRI News Should Have Been Expected (BIIB, ELN)

This morning’s share price reaction seen in Biogen-Idec Inc. (NASDAQ: BIIB) and Elan Corp. plc (NYSE: ELN) is severe. We…

Douglas A. McIntyre | Jul 31, 2008 at 6:59 AM EDT

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Another biotech giant is biting the dust via a buyout offer. ImClone Systems Inc. (NASDAQ: IMCL) has been given a…

Douglas A. McIntyre | Jul 29, 2008 at 4:09 PM EDT

Align’s Guidance: Wearing a Retainer in Public (ALGN)

Align Technology Inc. (NASDAQ: ALGN) has just posted some mixed earnings. Regardless of Wall Street’s and Main Street’s love of…

Douglas A. McIntyre | Jul 28, 2008 at 3:23 PM EDT

Amgen Defying Earnings Concerns (AMGN)

Earnings out of Amgen Inc. (NASDAQ: AMGN) appear to be strong enough to defy any notions that the big osteoporosis…

Douglas A. McIntyre | Jul 28, 2008 at 12:50 PM EDT

Amgen Earnings Now A Coin Toss? (AMGN)

After today’s close, we’ll be getting earnings out of biotech giant Amgen Inc. (NASDAQ: AMGN). It’s amazing how the company’s…

Douglas A. McIntyre | Jul 27, 2008 at 10:52 AM EDT

Looking for the Next Intuitive Surgical After The Barron’s Pan (ISRG, HNSN, NUVA)

This weekend and this last week has created a lot of buzz around the mighty medical robotics player Intuitive Surgical…

Douglas A. McIntyre | Jul 25, 2008 at 8:21 AM EDT

IPO FILING: AutoGenomics Inc.

Apparently the IPO filing hiatus isn’t entirely a dead end story. A company called AutoGenomics, Inc. has filed a registration…

Douglas A. McIntyre | Jul 24, 2008 at 7:02 AM EDT

GE Makes a Health Care Acquisition (GE, VITL)

Vital Signs Inc. (NASDAQ: VITL) is going to gap way up this morning. The company is being acquired by General…

Douglas A. McIntyre | Jul 23, 2008 at 2:17 PM EDT

Genentech & Roche Merger Coming Under More Fire (DNA)

Genentech Inc. (NYSE: DNA) is running into some issues over the merger with Roche at $89.00 per share. Wall Street…

Douglas A. McIntyre | Jul 22, 2008 at 8:50 AM EDT

State Street International Health Care ETF Launch (STT, IRY)

State Street Corporation (NYSE: STT) has announced that its State Street Global Advisors unit is launching 10 new SPDR exchange-traded…

1 … 348 349 350 351 352 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Illumina Gets Secondary Behind It (ILMN)

Alnylam Cancels Conference… What’s Brewing? (ALNY)

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

CardioNet Defies Prior Secondary Trends (BEAT)

Why Biogen & Elan TYSABRI News Should Have Been Expected (BIIB, ELN)

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Align’s Guidance: Wearing a Retainer in Public (ALGN)

Amgen Defying Earnings Concerns (AMGN)

Amgen Earnings Now A Coin Toss? (AMGN)

Looking for the Next Intuitive Surgical After The Barron’s Pan (ISRG, HNSN, NUVA)

IPO FILING: AutoGenomics Inc.

GE Makes a Health Care Acquisition (GE, VITL)

Genentech & Roche Merger Coming Under More Fire (DNA)

State Street International Health Care ETF Launch (STT, IRY)

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Health and Healthcare Articles

All Health and Healthcare Articles

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Illumina Gets Secondary Behind It (ILMN)

Alnylam Cancels Conference… What’s Brewing? (ALNY)

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

CardioNet Defies Prior Secondary Trends (BEAT)

Why Biogen & Elan TYSABRI News Should Have Been Expected (BIIB, ELN)

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Align’s Guidance: Wearing a Retainer in Public (ALGN)

Amgen Defying Earnings Concerns (AMGN)

Amgen Earnings Now A Coin Toss? (AMGN)

Looking for the Next Intuitive Surgical After The Barron’s Pan (ISRG, HNSN, NUVA)

IPO FILING: AutoGenomics Inc.

GE Makes a Health Care Acquisition (GE, VITL)

Genentech & Roche Merger Coming Under More Fire (DNA)

State Street International Health Care ETF Launch (STT, IRY)

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts